SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-082037
Filing Date
2021-06-16
Accepted
2021-06-16 16:38:08
Documents
12
Period of Report
2021-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119936d1_8k.htm   iXBRL 8-K 31158
  Complete submission text file 0001104659-21-082037.txt   206324

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA akya-20210611.xsd EX-101.SCH 3023
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE akya-20210611_lab.xml EX-101.LAB 34238
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akya-20210611_pre.xml EX-101.PRE 22357
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2119936d1_8k_htm.xml XML 3716
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 211021954
SIC: 3826 Laboratory Analytical Instruments